[Preliminary clinical observations with an antidepressive-anxiolytic preparation Wy-3263-WY-3498 (iprindo + oxazepam)].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000008:administration & dosage*; D001008:Anxiety Disorders / Q000188:drug therapy; D003863:Depression / Q000188:drug therapy; D004338:Drug Combinations; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007211:Indoles / Q000008:administration & dosage*; D007488:Iprindole / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy*; D010076:Oxazepam / Q000008:administration & dosage* / Q000627:therapeutic use
D000928:Antidepressive Agents; D004338:Drug Combinations; D007211:Indoles; D007488:Iprindole; D010076:Oxazepam
Observaç oes clínicas preliminares com a preparaç ao antidepressivo-ansiolítica WY-3263-WY-3498 (iprindol + oxazepam.